• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine.

作者信息

Swanson M C, Rosanoff E, Gurwith M, Deitch M, Schnurrenberger P, Reed C E

出版信息

J Infect Dis. 1987 May;155(5):909-13. doi: 10.1093/infdis/155.5.909.

DOI:10.1093/infdis/155.5.909
PMID:3559291
Abstract

We examined the antibody response to a rabies vaccine doubly inactivated with 0.025% beta-propiolactone and 0.1% tri(n)butyl phosphate and stabilized with 2.5% human serum albumin. Antibodies were measured by using the following four antigen preparations: complete doubly inactivated rabies vaccine, rabies vaccine inactivated only with tri(n)butyl phosphate, beta-propiolactone and human serum albumin, and human serum albumin alone. The fluid phase of the preparation of beta-propiolactone and human serum albumin completely inhibited IgE binding to solid-phase vaccine. Of 21 subjects with urticarial reactions to a booster, 19 had IgE to doubly inactivated vaccine and to beta-propiolactone and human serum albumin. None of 27 immunized subjects without urticaria had detectable IgE. In paired pre- and postimmunization sera, IgE appeared in six of seven of the subjects with urticaria and in one of seven nonreactors. These sera did not contain a significant level of IgE to singly inactivated vaccine or to human serum albumin alone.

摘要

相似文献

1
IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine.
J Infect Dis. 1987 May;155(5):909-13. doi: 10.1093/infdis/155.5.909.
2
The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.特异性IgE和β-丙内酯在人二倍体细胞狂犬病疫苗加强剂量引发的反应中的作用。
J Allergy Clin Immunol. 1987 Dec;80(6):861-8. doi: 10.1016/s0091-6749(87)80278-6.
3
Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine.
J Allergy Clin Immunol. 1987 Apr;79(4):605-10. doi: 10.1016/s0091-6749(87)80156-2.
4
Sensitization induced in guinea pigs with beta-propiolactone-treated serum albumin: experimental evidence for the cause of allergic reactions in humans receiving human diploid cell rabies vaccines.用β-丙内酯处理的血清白蛋白在豚鼠中诱导致敏:接受人二倍体细胞狂犬病疫苗的人类发生过敏反应原因的实验证据。
Int Arch Allergy Appl Immunol. 1986;80(1):110-1. doi: 10.1159/000234035.
5
[Immunogenicity of the rabies virus treated with phenol, beta-propiolactone and heat].[经苯酚、β-丙内酯和加热处理的狂犬病病毒的免疫原性]
Veterinariia. 1980 Mar(3):32-3.
6
Rhesus diploid rabies vaccine (adsorbed): a new rabies vaccine using FRhL-2 cells.吸附型恒河猴二倍体细胞狂犬病疫苗:一种使用FRhL-2细胞的新型狂犬病疫苗。
J Infect Dis. 1985 Jul;152(1):204-10. doi: 10.1093/infdis/152.1.204.
7
Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.用β-丙内酯灭活的狂犬病疫苗(固定狂犬病病毒巴贝斯株)
Arch Roum Pathol Exp Microbiol. 1981 Oct-Dec;40(4):333-9.
8
[Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].按照埃森暴露后接种程序用HDCS疫苗免疫的人群中狂犬病特异性IgM和IgG抗体反应(作者译)
Zentralbl Bakteriol Orig A. 1979 Dec;245(4):429-41.
9
[Results of human immunization with a new rabies vaccine containing no neuroallergenic brain tissue factor].[不含神经变应原脑组织因子的新型狂犬病疫苗人体免疫接种结果]
Vopr Virusol. 1984 Jul-Aug;29(4):437-41.
10
[Properties and potency of a rabies vaccine produced on the brain matter of young goats and inactivated by beta-propiolactone].
Dev Biol Stand. 1978;41:217-24.

引用本文的文献

1
Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.用于分子、血清学或疫苗开发目的的高致病性病毒灭活方法。
Pathogens. 2022 Feb 19;11(2):271. doi: 10.3390/pathogens11020271.
2
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.疫苗与过敏反应:过去、当前的 COVID-19 大流行及未来展望。
Allergy. 2021 Jun;76(6):1640-1660. doi: 10.1111/all.14840. Epub 2021 Jun 4.
3
Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy.
利用等离子体激活水制备鸡新城疫灭活疫苗及其免疫保护效果评价。
Appl Microbiol Biotechnol. 2020 Jan;104(1):107-117. doi: 10.1007/s00253-019-10106-8. Epub 2019 Nov 16.
4
Application of radiation technology in vaccines development.辐射技术在疫苗研发中的应用。
Clin Exp Vaccine Res. 2015 Jul;4(2):145-58. doi: 10.7774/cevr.2015.4.2.145. Epub 2015 Jul 29.
5
Development of a new hydrogen peroxide–based vaccine platform.新型基于过氧化氢的疫苗平台的开发。
Nat Med. 2012 Jun;18(6):974-9. doi: 10.1038/nm.2763.
6
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.对已获许可的病毒疫苗、其中一些安全性问题以及研究性病毒疫苗开发进展的综述。
J Infect. 2004 Oct;49(3):179-209. doi: 10.1016/j.jinf.2004.05.018.
7
Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients.青霉素酰基团与白蛋白的结合以及青霉素治疗患者中抗青霉素酰抗体的出现。
J Clin Invest. 1988 Jul;82(1):7-12. doi: 10.1172/JCI113603.